Expand ADVM Menu

ADVM Stock Summary and Trading Ideas (Adverum Biotechnologies | NASDAQ:ADVM)

Charts for Today's Stock Price and Implied Volatility in Adverum Biotechnologies

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for ADVM by Theoretical Edge and Win Rates


Trading Statistics

Key Ratios

Adverum Biotechnologies (ADVM) Frequently Asked Questions

What does Adverum Biotechnologies do?

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections.

What symbol and exchange does Adverum Biotechnologies stock trade?

Adverum Biotechnologies trades on the NASDAQ stock market under the symbol ADVM.

What is Adverum Biotechnologies stock price doing today?

As of March 27, 2023, ADVM stock price climbed to $0.78 with 65,021 million shares trading.

What is Adverum Biotechnologies's Beta?

ADVM has a beta of 0.65, meaning it tends to be less sensitive to market movements. ADVM has a correlation of 0.06 to the broad based SPY ETF.

How much is Adverum Biotechnologies worth?

ADVM has a market cap of $77.79 million. This is considered a Micro Cap stock.

What is the highest and lowest price Adverum Biotechnologies traded in the last 3 year period?

In the last 3 years, ADVM stock traded as high as $26.98 and as low as $.53.

What are the top ETFs holding Adverum Biotechnologies?

The top ETF exchange traded funds that ADVM belongs to (by Net Assets): VTI, VXF, IWC, ITOT, DFAU.

Is Adverum Biotechnologies (ADVM) a good investment?

ADVM has underperformed the market in the last year with a price return of -44.3% while the SPY ETF lost -10.6%. However, in the short term, ADVM had mixed performance relative to the market. It has outperformed in the last 3 months, returning +36.8% vs +3.8% return in SPY. But in the last 2 weeks, ADVM shares have been beat by the market, returning -1.3% compared to an SPY return of +3.0%.

What is the support and resistance for Adverum Biotechnologies (ADVM) stock price?

ADVM support price is $.72 and resistance is $.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADVM stock will trade within this expected range on the day.